Navigation Links
New Web Sites Educate About Triglycerides and HDL Cholesterol
Date:11/12/2009

ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Nearly one in three adult Americans have triglyceride (trig) levels that are above normal and nearly 34 million have low HDL "good" cholesterol levels. To help increase awareness about the importance of HDL and trigs, Abbott has launched two Web sites: www.knowyourhdl.com and www.knowyourtrigs.com.

"Unhealthy high triglyceride and low HDL levels are factors that can raise the risk of heart disease," said Eliot A. Brinton, M.D., associate professor, University of Utah, School of Medicine. "Understanding cholesterol and lipids, fats found in the blood, can be confusing, but it's important patients know what HDL and triglycerides are and how they can affect heart health."

Often, cholesterol conversations center on LDL, the "bad" cholesterol. These Web sites focus on commonly overlooked HDL and trigs and the role they play in health. Other information featured includes tips on diet, exercise and how patients can talk to their doctor about their risk factors for heart disease.

"Abbott has a long-standing commitment to patient education and providing tools patients need to take a proactive approach to managing their health," said Darryl Sleep, M.D., Dyslipidemia project director, Abbott. "These new Web sites encourage education, a healthy lifestyle and communication with physicians to help patients better understand important heart disease risk factors."

About HDL Cholesterol

There are two sources of HDL cholesterol: the liver and food. According to the American Heart Association, a low level of HDL cholesterol (less than 40 mg/dL for men and less than 50 mg/dL for women) may increase the risk of developing heart disease. However, a high level of HDL cholesterol (60 mg/dL or more) may protect against heart disease.

About Triglycerides

Triglycerides are lipids, fats found in the blood, made by the body and found in food. In normal amounts (less than 150 mg/dL), triglycerides help provide energy and are important to one's health. However, high amounts of triglycerides (200 mg/dL or more) can contribute to the hardening and narrowing of blood vessels, making it hard for blood to flow and increasing the risk for heart disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
3. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
4. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
5. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
6. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
7. Parasites That Live Inside Cells Use Loophole to Thwart Immune System
8. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
9. CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
10. Radius Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
11. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... , June 23, 2016  The National ... has joined the health policy research organization as ... Romano , MD, senior vice president and chief ... company,s representative on the NPC Board of Directors. ... pleased that Mallinckrodt has joined us in support ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):